Search

everythinglearnresearchcommunity

for

Search:↓

Goat placenta extract in a special delivery system improved hair growth and thickness in chemotherapy patients.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Some herbal medicines can interfere with chemotherapy, affecting treatment and causing side effects.

Tofacitinib helped regrow hair in a woman with alopecia areata.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

The document concludes that the FOLLYSIS© system improves hair transplant processes and patient monitoring with high accuracy and less skin trauma.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Glioma treatment may improve with new therapies and technologies.

Povidone-iodine nail solution effectively treats nail infections caused by chemotherapy.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

FA-MNPs effectively targeted and killed cancer cells but didn't overcome drug resistance.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

Most pediatric cancer patients in the study developed skin problems, often due to their cancer treatment.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

Weekly 5 mg folate is enough to prevent methotrexate toxicity in rheumatoid arthritis patients.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Scalp cooling effectively prevents hair loss in breast cancer patients undergoing chemotherapy.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

FOL-005 peptide can reduce human hair growth by lowering FGF7 levels.

Clofazimine may be effective for treating ashy dermatosis.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

FDG PET/CT scans can change cancer treatment plans for dogs.